The text starts here.

Non-Consolidated Semiannual Financial Report for fiscal 1997

PRINCIPAL NEW PRODUCTS

1. ETHICAL DRUG PRODUCTS

Product Name

Approved
Launch

Product Description

PICOLUMI PIVKA-II Jul-97
Jul-97
Tumor marker used for both complementary diagnosis and observation of therapeutic effect for hepato cellular carcinoma. In vitro diagnostic reagent kit based on electro-chemiluminescense immunoassay for measuring PIVKA-II in the blood.
PICOLUMI AFP Jul-97
Jul-97
Tumor marker used for both complementary diagnosis and observation of therapeutic effect for hepato cellular carcinoma. In vitro diagnostic reagent kit based on electro-chemiluminescence immunoassay for measuring AFP in the blood.
PICOLUMI CEA Jul-97
Aug-97
Tumor marker used for both complementary diagnosis and observation of progress for colon cancer, rectum cancer, and gastric cancer. In vitro diagnostic reagent kit based on electro-chemiluminescence immunoassay for measuring CEA in the blood.

2. CONSUMER HEALTHCARE PRODUCTS

Product Name

Launch

Product Description

NABOLIN EB Tablet Aug-97 An addition to the NABOLIN family of products. NABOLIN EB contains vitamin E, B1, B6 and active type B12. Aids in the relief of lower back pain and stiff shoulders.
SAHNE LIP Aug-97 Fosters increased blood circulation and protects the lips with vitamin E nicotinate and prevents chapping and cracking of lips with aloe extract.
KURTIME MK Sep-97 An addition to the Kurtime family of products. Concentrated fermented rice extract that relieves symptoms associated with a variety of skin disorders including eczema.